184 related articles for article (PubMed ID: 17407610)
1. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.
Puhan MA; Vollenweider D; Latshang T; Steurer J; Steurer-Stey C
Respir Res; 2007 Apr; 8(1):30. PubMed ID: 17407610
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
[TBL] [Abstract][Full Text] [Related]
4. Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review.
Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G
BMC Med; 2008 Oct; 6():28. PubMed ID: 18847478
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis.
Lee JS; Park DA; Hong Y; Jo KW; Lee SW; Huh JW; Oh YM; Lee SD
Int J Tuberc Lung Dis; 2013 Feb; 17(2):153-62. PubMed ID: 23317949
[TBL] [Abstract][Full Text] [Related]
8. Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study.
Boggon R; Hubbard R; Smeeth L; Gulliford M; Cassell J; Eaton S; Pirmohamed M; van Staa TP
BMC Pulm Med; 2013 May; 13():32. PubMed ID: 23724907
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis.
Dobler CC; Morrow AS; Beuschel B; Farah MH; Majzoub AM; Wilson ME; Hasan B; Seisa MO; Daraz L; Prokop LJ; Murad MH; Wang Z
Ann Intern Med; 2020 Mar; 172(6):413-422. PubMed ID: 32092762
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?
Jacobs DM; Pandit U; Sethi S
Curr Opin Infect Dis; 2019 Apr; 32(2):143-151. PubMed ID: 30672788
[TBL] [Abstract][Full Text] [Related]
11. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?
Balser E; Neher JO; Safranek S; Taraday J
J Fam Pract; 2006 Dec; 55(12):1079-80. PubMed ID: 17137546
[TBL] [Abstract][Full Text] [Related]
12. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Wang Y; Zijp TR; Bahar MA; Kocks JWH; Wilffert B; Hak E
J Antimicrob Chemother; 2018 Dec; 73(12):3231-3243. PubMed ID: 30189002
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
Wedzicha JA; Buhl R; Lawrence D; Young D
Respir Med; 2015 Jan; 109(1):105-11. PubMed ID: 25433954
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
[TBL] [Abstract][Full Text] [Related]
15. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review.
Puhan MA; Scharplatz M; Troosters T; Steurer J
Respir Res; 2005 Jun; 6(1):54. PubMed ID: 15943867
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Rothberg MB; Pekow PS; Lahti M; Brody O; Skiest DJ; Lindenauer PK
JAMA; 2010 May; 303(20):2035-42. PubMed ID: 20501925
[TBL] [Abstract][Full Text] [Related]
18. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
19. Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review.
Stolbrink M; Amiry J; Blakey JD
Chron Respir Dis; 2018 Aug; 15(3):225-240. PubMed ID: 29232988
[TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
